Abbott Laboratories (Pakistan) Limited (PSX:ABOT)
Pakistan
· Delayed Price · Currency is PKR 1,037.25
-5.53 (-0.53%)
At close: Feb 28, 2025
PSX:ABOT Revenue
In the year 2024, Abbott Laboratories (Pakistan) had annual revenue of 68.18B PKR with 22.90% growth. Abbott Laboratories (Pakistan) had revenue of 18.61B in the quarter ending December 31, 2024, with 30.62% growth.
Revenue
68.18B
Revenue Growth
+22.90%
P/S Ratio
1.49
Revenue / Employee
47.68M
Employees
1,430
Market Cap
101.55B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68.18B | 12.70B | 22.90% |
| Dec 31, 2023 | 55.48B | 6.22B | 12.62% |
| Dec 31, 2022 | 49.26B | 6.69B | 15.71% |
| Dec 31, 2021 | 42.57B | 7.29B | 20.65% |
| Dec 31, 2020 | 35.28B | 5.13B | 17.00% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GlaxoSmithKline Pakistan | 56.23B |
| AGP Limited | 23.45B |
| Highnoon Laboratories | 23.02B |
| The Searle Company | 28.32B |
| Shifa International Hospitals | 25.48B |
| Citi Pharma | 12.93B |
| Ferozsons Laboratories | 15.96B |
| Otsuka Pakistan | 3.37B |